If you have ever been told that you have to get sober before anyone will treat your depression, or that you have to get your anxiety under control before any addiction program will accept you, you have run into the model of care that the field has spent twenty years trying to retire. The sequential model fails on a predictable timeline, and the failure is not the client’s fault. The untreated condition keeps pulling at the recovery, and the substance use keeps pulling at the mental health treatment. The result is the pattern of fragmented, parallel, never-quite-stable care that so many families in the Roanoke Valley recognize from prior attempts.
The research is clear that more than half of adults with a substance use disorder also live with a mental health condition, most commonly depression, anxiety, post-traumatic stress, or bipolar disorder (NIDA, 2024).
At Roanoke Refuge, the dual diagnosis program integrates both into a single treatment plan, delivered by a single clinical team, in the same setting, on the same schedule. Integrated co-occurring disorders care is the model recognized by SAMHSA, by the American Society of Addiction Medicine, and by the American Psychiatric Association as the standard of care for people whose clinical picture includes both.
What Co-Occurring Disorders Actually Means
The clinical term co-occurring disorders refers to the presence of a substance use disorder and a mental health condition in the same person at the same time. In the older literature, the same picture is sometimes called dual diagnosis or comorbidity; the terms refer to the same clinical reality.
What matters is not the label but the underlying pattern: two conditions that interact with each other biologically, psychologically, and behaviorally, and that respond best to treatment designed around that interaction rather than around the separation of the two.
Co-occurring disorders are not rare and they are not unusual. According to the National Institute on Drug Abuse, an estimated 21.5 million adults in the United States have co-occurring conditions, and the overlap between mental health conditions and substance use disorders runs in both directions: people with mental health conditions are at substantially higher risk for substance use disorders, and people with substance use disorders are at substantially higher risk for mental health conditions (NIDA, 2024). The pattern is the rule, not the exception.
Why Sequential Treatment Fails
The model that says “treat the addiction first, then we will look at the depression” is built on an assumption that the substance use is the cause of the mental health symptoms and that the symptoms will resolve on their own with abstinence. For some people, in some narrow circumstances, that picture is partially true.
For the majority of adults with co-occurring conditions, the mental health condition is doing real, independent clinical work, and abstinence alone does not address it. What happens instead is that the person achieves a period of sobriety, the underlying condition reasserts itself with the substance no longer dampening the symptoms, and the most accessible coping strategy is the one that worked before. The cycle is predictable enough that the field rewrote the standard of care around it.
Integrated treatment closes that loop by treating both conditions in the same plan, using clinicians trained in both, with a single treatment plan rather than two parallel ones. The therapeutic groups, the individual sessions, and the case management work all carry both threads simultaneously. The goal is not to silo the substance use disorder treatment from the mental health treatment; the goal is to recognize that the two are different facets of the same picture in the same person.
The SAMHSA Integrated Care Model
The integrated co-occurring disorders model, developed in the late 1990s and refined through the 2000s, is grounded in evidence from the National Comorbidity Survey, the Epidemiologic Catchment Area study, and a generation of treatment-outcome research. The framework rests on several principles that shape clinical practice at Roanoke Refuge:
Integrated assessment
Both conditions are evaluated at intake, by the same clinical team, using validated screening tools for each.
Integrated treatment plan
One plan, addressing both conditions in coordinated rather than sequential fashion.
Integrated clinical team
Clinicians trained in both substance use disorder treatment and mental health treatment, rather than referrals between siloed providers.
Stage-matched intervention
Recognition that motivation to change varies by condition and over time, and that engagement strategies have to match where the person is in the process for each.
Long-term continuity
Recognition that co-occurring conditions are chronic and require continuing care planning across both axes.
Depression and Substance Use Disorder
Depression is the most common mental health condition that co-occurs with substance use disorder, and the bidirectional relationship is well documented. Major depression increases the risk of substance use disorder, and substance use disorder increases the risk of depression. Many people describe their substance use as an attempt to manage low mood, sleep disruption, anhedonia (the inability to feel pleasure), or hopelessness that has gone untreated for years. The pattern is so common that families almost always recognize it once it is named.
At Roanoke Refuge, depression and addiction are treated in the same plan, with the depression-specific therapeutic work woven through the substance use disorder curriculum. The work includes:
- Behavioral activation to rebuild engagement with daily life.
- Cognitive work on hopelessness and self-criticism.
- Sleep stabilization, since disrupted sleep is one of the most reliable depression drivers.
- Structured social re-engagement integrated with relapse-prevention work.
Anxiety and Substance Use Disorder
Anxiety disorders, including generalized anxiety disorder, panic disorder, and social anxiety disorder, frequently co-occur with substance use disorders. The most common substances used to manage anxiety are alcohol, benzodiazepines, and cannabis. Each carries a specific risk pattern:
Alcohol
builds tolerance and physical dependence and produces rebound anxiety during withdrawal.
Benzodiazepines
carry some of the most medically dangerous withdrawal of any substance class. Learn more
Chronic cannabis use
can paradoxically worsen anxiety over time despite the short-term reduction.
The anxiety and addiction track at Roanoke Refuge treats both conditions in the same plan. The cognitive and behavioral work on anxiety, the somatic and grounding skills for panic, and the exposure-based work for social anxiety run alongside the substance use disorder treatment rather than after it. For clients whose anxiety treatment may require non-controlled medication, our clinical team coordinates with the prescribing provider so the medication side and the therapy side are aligned rather than in conflict.
Trauma, PTSD, and Substance Use Disorder
The relationship between trauma and substance use disorder is one of the most consistent findings in the addiction medicine literature. Adverse childhood experiences, combat-related trauma, sexual assault, domestic violence, and other forms of trauma all substantially elevate the long-term risk of substance use disorder. For many adults who arrive at outpatient treatment with what looks like a primary substance use problem, the clinical picture beneath it is unresolved trauma that the substance use has been suppressing.
Trauma and PTSD treatment at Roanoke Refuge is trauma-informed across the entire program, not a specialty track added on the side. The clinical work includes psychoeducation about the neurobiology of trauma, skills-based stabilization, and trauma-specific therapeutic approaches as clinically appropriate. For veterans with combat-related PTSD, our clinical team coordinates with Salem VAMC and Vet Center Roanoke as part of the continuing care network for clients who use those resources.
Psychiatric Medication Coordination
Roanoke Refuge prescribes FDA-approved MAT medications on-site as part of integrated dual diagnosis care. Psychiatric medication management for co-occurring conditions — antidepressants, mood stabilizers, antipsychotics — is coordinated with an outside prescriber, either your existing psychiatrist, primary care physician, or a community psychiatric prescriber we can connect you with during admissions.
What this means in practice: the medication side of the plan is coordinated rather than fragmented. Clients prescribed antidepressants, anxiolytics (when clinically appropriate and not contraindicated by the substance use history), mood stabilizers, or other psychiatric medications continue with their prescribing provider while our clinical team coordinates communication so the treatment plan stays consistent across providers.
MAT for substance-specific medications (buprenorphine, naltrexone, acamprosate, disulfiram) is prescribed directly on-site by our medical team; methadone is dispensed only through certified Opioid Treatment Programs by federal law, and we coordinate with community OTPs for clients best served by methadone.
Why the Roanoke Valley Specifically Needs This Care
The substance use crisis in Southwest Virginia is well documented, and the Roanoke Valley sits inside it. The Virginia Department of Health’s most recent Roanoke Health District reporting shows continued elevation in fatal drug overdoses across the region, with the opioid epidemic and the more recent rise in fentanyl-involved deaths shaping the local clinical picture (Virginia Department of Health, Roanoke Health District, 2024). The same data shows that overdose deaths involving people with documented prior mental health conditions remain a substantial share of the total, which is consistent with the national picture of co-occurring disorders in the overdose crisis.
What that data means clinically: the people most at risk are the people with the most layered clinical pictures. Treating only the substance use, without treating the depression that drove much of the use, or the trauma that underlies much of the depression, leaves the most dangerous element of the picture in place. Integrated dual diagnosis care is not a luxury layer of treatment for clients with means; it is the standard of care for the clinical reality of substance use disorder in this region.
The Levels of Care for Dual Diagnosis
Integrated dual diagnosis care at Roanoke Refuge is available at every level of care the program offers:
- PHP at full-day outpatient integrates dual diagnosis work into the structured therapeutic day.
- IOP at part-day outpatient integrates it into the nine or more clinical hours weekly that fit around work and family.
- Telehealth IOP delivers the same integrated curriculum through a secure video platform for clients across Virginia where the in-person commute is a barrier.
The level of care is determined by the clinical assessment at admissions; dual diagnosis care runs through whichever level fits the clinical picture.
Local, regional, and accessible.
Roanoke Refuge serves adults across the Roanoke Valley — Roanoke City, Salem, Vinton, and the surrounding counties of Roanoke, Botetourt, and Bedford — from a facility at 1630 Braeburn Drive in Salem, just off I-81. Most clients are within a 30-minute drive of the program.
The path forward is a conversation, not a commitment. A short call with the Roanoke Refuge admissions team covers fit, level of care, and insurance — at no cost, with full confidentiality, before any clinical decisions are made. Insurance verification runs during the same call. Call (540) 900-0353 when you are ready.